Allied Market Research published a report, titled, “Angioplasty Balloons Market by Type (Normal Balloons, Drug Eluting Balloons, Cutting Balloons and Scoring Balloons), Application (Peripheral and Coronary), and End User (ASCs, Hospitals and Cath Labs): Global Opportunity Analysis and Industry Forecast, 2024-2033″. According to the report, the angioplasty balloons market was valued at $2.6 billion in 2023, and is estimated to reach $3.6 billion by 2033, growing at a CAGR of 3.4% from 2024 to 2033.
๐๐ก๐๐ญ ๐๐ซ๐ ๐ญ๐ก๐ ๐๐ซ๐ข๐ฏ๐ข๐ง๐ ๐๐๐๐ญ๐จ๐ซ๐ฌ ๐๐จ๐ซ ๐ญ๐ก๐ ๐๐ง๐ ๐ข๐จ๐ฉ๐ฅ๐๐ฌ๐ญ๐ฒ ๐๐๐ฅ๐ฅ๐จ๐จ๐ง๐ฌ ๐๐๐ซ๐ค๐๐ญ?
The angioplasty balloons market has experienced robust growth driven by several key factors such as increasing prevalence of cardiovascular diseases, advancements in balloon catheter technologies, and the growing preference for minimally invasive procedures. The rise in geriatric populations, coupled with lifestyle factors such as poor diet, lack of exercise, and smoking, has contributed to the surge in coronary artery disease cases, necessitating effective treatment options such as angioplasty. Technological innovations, including drug-eluting balloons and cutting-edge catheter designs, have enhanced the efficacy and safety of angioplasty procedures, further propelling market growth. In addition, the expanding healthcare infrastructure in emerging economies and the rising awareness about early diagnosis and treatment of heart diseases are expected to fuel market demand. Overall, the angioplasty balloon market is poised for steady growth, driven by the continuous need for advanced cardiovascular care solutions.
๐๐๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐ฐ๐ข๐ญ๐ก ๐๐ซ๐๐ฉ๐ก๐ฌ ๐๐ง๐ ๐ ๐ข๐ ๐ฎ๐ซ๐๐ฌ ๐๐๐ซ๐: https://www.alliedmarketresearch.com/request-sample/A38595
๐๐จ๐ฉ ๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ ๐จ๐ ๐ญ๐ก๐ ๐๐ง๐ ๐ข๐จ๐ฉ๐ฅ๐๐ฌ๐ญ๐ฒ ๐๐๐ฅ๐ฅ๐จ๐จ๐ง๐ฌ ๐๐๐ซ๐ค๐๐ญ
- Abbott Laboratories
- Braun Melsungen AG
- BIOTRONIK SE & Co. KG
- Boston Scientific Corporation
- R. Bard, Inc.
- Cardinal Health, Inc.
- Medtronic plc.
- MicroPort Scientific Corporation
- Terumo Corporation
- THE SPECTRANETICS CORPORATION
๐๐ง๐ ๐ข๐จ๐ฉ๐ฅ๐๐ฌ๐ญ๐ฒ ๐๐๐ฅ๐ฅ๐จ๐จ๐ง๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐ฌ๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง ๐๐๐ง ๐๐ ๐๐จ๐ง๐ ๐๐๐ฌ๐๐ ๐จ๐ง ๐ฌ๐๐ฏ๐๐ซ๐๐ฅ ๐๐๐๐ญ๐จ๐ซ๐ฌ, ๐ข๐ง๐๐ฅ๐ฎ๐๐ข๐ง๐ :
By type, the normal balloons segment held the largest share of the market in 2023. This dominance is primarily due to several factors that make normal balloons highly attractive in clinical practice. First, normal balloons are cost-effective compared to their specialized counterparts like drug-eluting balloons (DEBs) and scoring balloons. This affordability makes them accessible to a broader patient base and healthcare facilities, driving their widespread adoption. Additionally, normal balloons benefit from streamlined regulatory approval processes and supportive reimbursement policies in many regions, facilitating easier market entry and uptake.
By application, the coronary segment accounted for the largest share in 2023 in angioplasty balloons market. The growth is attributed to the fact that coronary artery disease (CAD) remains one of the most prevalent cardiovascular conditions globally, necessitating frequent interventions to alleviate symptoms and improve patient outcomes. Coronary angioplasty involves balloons to widen narrowed or blocked arteries supplying blood to the heart, thereby restoring adequate blood flow, and reducing the risk of heart attacks. The high incidence of CAD, coupled with advancements in balloon catheter technologies and favorable reimbursement policies in many regions, drives significant demand for coronary angioplasty balloons.
By end user, the ASCs segment accounted for the largest share in 2023 and is expected to exhibit the highest growth during the forecast period due to huge demand for treatments in these settings. This is attributed to the availability of advanced services and minimum hospital stay requirements. In addition, treatments performed in ASCs are cost-effective, which helps cut down on overall medical expenses.
By region, North America held the largest market share in terms of revenue in 2023 and is expected to dominate the market during the forecast period. This is attributed to rise in occurrences of coronary heart disease, rise in disposable income, increase in knowledge of heart diseases and associated treatments, and better healthcare infrastructure. Additionally, favorable regulatory frameworks and significant investments in research and development further propel market growth in this region.
๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐ญ๐ก๐ ๐๐๐ฉ๐จ๐ซ๐ญ: https://www.alliedmarketresearch.com/purchase-enquiry/A38595
๐๐ฎ๐ซ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐จ๐ฅ๐ฎ๐ญ๐ข๐จ๐ง ๐๐ซ๐จ๐ฏ๐ข๐๐๐ฌ ๐๐จ๐ฎ ๐๐ง๐ฌ๐ฐ๐๐ซ ๐ญ๐จ ๐๐๐ฅ๐จ๐ฐ ๐๐๐ง๐ญ๐ข๐จ๐ง๐๐ ๐๐ฎ๐๐ฌ๐ญ๐ข๐จ๐ง:
- Which are the driving factors responsible for the growth of market?
- Which are the roadblock factors of this market?
- What are the new opportunities, by which market will grow in coming years?
- What are the trends of this market?
- Which are main factors responsible for new product launch?
- How big is the global & regional market in terms of revenue, sales and production?
- How far will the market grow in forecast period in terms of revenue, sales and production?
- Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
- How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
- Which region has more opportunities?
๐๐๐ ๐ข๐จ๐ง ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ:-
- North America
(U.S., Canada, Mexico)
- Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
- Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
- LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
๐๐จ๐ง๐ญ๐๐๐ญ ๐๐๐ญ๐๐ข๐ฅ๐ฌ:
David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
๐๐๐จ๐ฎ๐ญ ๐๐ฌ
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of โMarket Research Reportsโ and โBusiness Intelligence Solutions.โ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
